These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 9204440)
41. The structure and function of catalytic RNAs. Wu Q; Huang L; Zhang Y Sci China C Life Sci; 2009 Mar; 52(3):232-44. PubMed ID: 19294348 [TBL] [Abstract][Full Text] [Related]
42. A general strategy for effector-mediated control of RNA-cleaving ribozymes and DNA enzymes. Wang DY; Lai BH; Sen D J Mol Biol; 2002 Apr; 318(1):33-43. PubMed ID: 12054766 [TBL] [Abstract][Full Text] [Related]
43. A ribozyme composed of only two different nucleotides. Reader JS; Joyce GF Nature; 2002 Dec 19-26; 420(6917):841-4. PubMed ID: 12490955 [TBL] [Abstract][Full Text] [Related]
44. Relating conformation, Mg2+ binding, and functional group modification in the hammerhead ribozyme. Chartrand P; Leclerc F; Cedergren R RNA; 1997 Jul; 3(7):692-6. PubMed ID: 9214652 [No Abstract] [Full Text] [Related]
45. In vitro selection of hemin-binding catalytic RNA. Liu M; Kagahara T; Abe H; Ito Y Bioorg Med Chem Lett; 2009 Mar; 19(5):1484-7. PubMed ID: 19179075 [TBL] [Abstract][Full Text] [Related]
46. Design and in vitro activity of ribozymes against mRNA of a rat membrane inhibitor of complement. Inui O; Tanaka T; Dohi N; Okada N; Okada H; Kikuchi Y Nucleic Acids Symp Ser; 1997; (37):223-4. PubMed ID: 9586080 [TBL] [Abstract][Full Text] [Related]
47. A covalent crosslink converts the hammerhead ribozyme from a ribonuclease to an RNA ligase. Stage-Zimmermann TK; Uhlenbeck OC Nat Struct Biol; 2001 Oct; 8(10):863-7. PubMed ID: 11573091 [TBL] [Abstract][Full Text] [Related]
49. Is your ribozyme design really correct?: A proposal of simple single turnover competition assay to evaluate ribozymes. Tanaka T; Inui O; Dohi N; Okada N; Okada H; Kikuchi Y Biosci Biotechnol Biochem; 2001 Jul; 65(7):1636-44. PubMed ID: 11515549 [TBL] [Abstract][Full Text] [Related]
50. The 5'-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity. Yokoyama Y; Takahashi Y; Shinohara A; Wan X; Takahashi S; Niwa K; Tamaya T Biochem Biophys Res Commun; 2000 Jun; 273(1):316-21. PubMed ID: 10873604 [TBL] [Abstract][Full Text] [Related]
51. Acquisition of novel catalytic activity by the M1 RNA ribozyme: the cost of molecular adaptation. Cole KB; Dorit RL J Mol Biol; 1999 Oct; 292(4):931-44. PubMed ID: 10525416 [TBL] [Abstract][Full Text] [Related]
52. PCR-based construction of long hammerhead ribozymes. Zillmann M; Robinson G Methods Mol Biol; 1997; 74():131-9. PubMed ID: 9204428 [No Abstract] [Full Text] [Related]
53. Post-synthetically ligated ribozymes: an alternative approach to iterative solid-phase synthesis. Bellon L; Workman CT; Jarvis TC; Wincott FE Bioconjug Chem; 1997; 8(2):204-12. PubMed ID: 9095362 [TBL] [Abstract][Full Text] [Related]
54. Enzymatic synthesis and characterization of unmodified ribozymes and substrates. Krupp G Methods Mol Biol; 1997; 74():79-89. PubMed ID: 9204423 [No Abstract] [Full Text] [Related]
56. Design of hammerhead ribozymes to distinguish single base changes in substrate RNA. Singh KK; Schluff P; Lehnert L; Krupp G Antisense Nucleic Acid Drug Dev; 1996; 6(3):165-8. PubMed ID: 8915500 [TBL] [Abstract][Full Text] [Related]